Journal Article
Review
Add like
Add dislike
Add to saved papers

Tissue-specific Role of CX 3 CR1 Expressing Immune Cells and Their Relationships with Human Disease.

Immune Network 2018 Februrary
Chemokine (C-X3-C motif) ligand 1 (CX3 CL1, also known as fractalkine) and its receptor chemokine (C-X3-C motif) receptor 1 (CX3 CR1) are widely expressed in immune cells and non-immune cells throughout organisms. However, their expression is mostly cell type-specific in each tissue. CX3 CR1 expression can be found in monocytes, macrophages, dendritic cells, T cells, and natural killer (NK) cells. Interaction between CX3 CL1 and CX3 CR1 can mediate chemotaxis of immune cells according to concentration gradient of ligands. CX3 CR1 expressing immune cells have a main role in either pro-inflammatory or anti-inflammatory response depending on environmental condition. In a given tissue such as bone marrow, brain, lung, liver, gut, and cancer, CX3 CR1 expressing cells can maintain tissue homeostasis. Under pathologic conditions, however, CX3 CR1 expressing cells can play a critical role in disease pathogenesis. Here, we discuss recent progresses of CX3 CL1/CX3 CR1 in major tissues and their relationships with human diseases.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app